Login
Sign Up
Login
Sign Up
Features
Pricing
Reg.News
Contact
Login
Sign Up
Search
Providers
Companies
⨯
LIVE
Event in Progress:
Join Here
×
Search
Providers
Companies
⨯
Features
Pricing
Event Hub
Reg.News
Short Interest
Contact
All the news articles and press releases in one place.
UK Reg. News
German Reg. News
Search
Key Announcements
Results / Trading Updates
Get free RNS email alerts for@Model.CurrentFilterValue
Currently filtered for Physiomics Plc
Clear Filter
Sector
Automobile Industry
Banks
Basic Materials
Building & Construction
Chemicals
Consumer Discretionary Goods
Consumer Discretionary Services
Consumer Staple Goods
Consumer Staple Services
Discretionary Personal Goods
Discretionary Retail
Energy
ETFs
Finance
Financial Services
Food & Drink
Food Production
Health
Household Goods & DIY
Industrial
Industrial Equipment, Goods & Services
Insurance & Reinsurance
Investment Trusts
Leisure, Tourism & Travel
Media
Open-ended Funds
Other
Real Estate
Resources
Staple Retail
Technology
Telecoms
Trusts, ETFs & Funds
Utilities
Market Cap
Below £20m
£20m - £100m
£100m - £300m
£300m - £1bn
£1bn - £10bn
Over £10bn
Filters »
All
UK100
UK250
UK SmallCap
UK Other
Show:
10
25
50
100
«
1
2
»
Date / Time
Source
Ticker
Company
Sector
Market Cap
Announcement
04Aug20 07:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Trading update
31Jul20 07:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Physiomics awarded contract by Astellas Pharma Inc
22Jul20 11:45
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Share Price Movement
06Jul20 10:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Director dealing
30Jun20 14:30
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Contract award and update
22Jun20 07:00
RNS-R
PYC:LON
Physiomics Plc
Other
£2.10m
Conference presentation
10Jun20 13:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Holding(s) in Company
27May20 07:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Fundraise
15May20 13:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Holding(s) in Company
28Apr20 14:50
RNS-R
PYC:LON
Physiomics Plc
Other
£2.10m
Conference attendance and presentation
16Apr20 07:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Confirmation of Twitter account
09Apr20 12:28
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Holding(s) in Company
06Apr20 07:00
RNS-R
PYC:LON
Physiomics Plc
Other
£2.10m
Awarded further Bicycle Therapeutics contract
19Mar20 07:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
COVID-19 update
10Mar20 07:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
NIHR i4i award
05Mar20 07:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Physiomics awarded further contract by Merck
03Mar20 07:01
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Interim Results
03Mar20 07:00
RNS-R
PYC:LON
Physiomics Plc
Other
£2.10m
Awarded two further contracts by Bicycle
27Dec19 15:45
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Holding(s) in Company
23Dec19 07:00
RNS-R
PYC:LON
Physiomics Plc
Other
£2.10m
Contract award
20Dec19 10:30
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Merck Contracts
19Nov19 12:52
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Result of AGM
21Oct19 07:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Dispatch of Annual Report and Notice of AGM
30Sep19 07:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Final Results for the Year Ended 30 June 2019
05Aug19 07:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Director Dealing
30Jul19 07:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Trading Update
22Jul19 09:03
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Holding(s) in Company
08Jul19 07:00
RNS-R
PYC:LON
Physiomics Plc
Other
£2.10m
Agreement with Bicycle and Cancer Research UK
02Jul19 13:30
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Holding(s) in Company
28Jun19 07:00
RNS-R
PYC:LON
Physiomics Plc
Other
£2.10m
Contract Award
31May19 07:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Change of Adviser
14May19 07:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Innovate UK Award Project
03May19 12:00
RNS-R
PYC:LON
Physiomics Plc
Other
£2.10m
Physiomics participates at NIHR event
30Apr19 14:00
RNS-R
PYC:LON
Physiomics Plc
Other
£2.10m
Conference attendance and presentation
27Mar19 13:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Issue of Options
26Mar19 13:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
AIM Rule 26 Website Change
20Mar19 07:00
RNS-R
PYC:LON
Physiomics Plc
Other
£2.10m
Conference Attendance and Presentation
21Feb19 07:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Interim Results
07Jan19 07:00
RNS-R
PYC:LON
Physiomics Plc
Other
£2.10m
Conference Attendance
03Jan19 07:00
RNS-R
PYC:LON
Physiomics Plc
Other
£2.10m
Strategic Collaboration
17Dec18 07:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Renewal of Agreement with Merck
20Nov18 12:56
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Result of AGM
15Oct18 13:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Dispatch of Annual Report and Shareholder Circular
08Oct18 07:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Final Results for the Year Ended 30 June 2018
09Aug18 07:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Contract award
21Jun18 07:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Trading Update
23May18 07:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Placing
26Apr18 11:06
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Contract Award
06Apr18 14:40
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Director/PDMR Shareholding
27Mar18 17:23
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Issue of Options
14Mar18 07:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Award of New Innovate UK Grant
19Feb18 07:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Interim Results Statement
09Feb18 07:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Contract Award
26Jan18 07:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
New Major Pharmaceutical Client
25Jan18 13:34
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Holding(s) in Company
24Jan18 08:46
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Holding(s) in Company
19Jan18 10:20
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Holding(s) in Company
17Jan18 15:52
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Holding(s) in Company
13Dec17 14:06
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Result of AGM
12Dec17 10:17
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Director Dealing
06Dec17 15:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Issue of Equity
30Nov17 13:38
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Share Price Movement
28Nov17 07:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Clinical Project Completion and Services Agreement
09Nov17 07:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Dispatch of Annual Report and Shareholder Circular
16Oct17 07:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Final Results
02Oct17 07:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Company Update
31Jul17 07:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Two New Pre-Clinical Contracts
05May17 07:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Physiomics to Present at BioTrinity 2017
24Mar17 11:15
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Interim Results Statement
11Jan17 07:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Company Update
06Jan17 07:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Confirmation of Award of Innovate UK Grant
22Dec16 15:31
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Director Dealing
22Dec16 07:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Issue of Options
16Dec16 13:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Result of AGM
05Dec16 07:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Payment for in-silico modelling of inhibitor
23Nov16 07:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Posting of Financial Results and Notice of AGM
22Nov16 07:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Provisional Award of Innovate UK Grant
27Oct16 15:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Final Results for the year ended 30 June 2016
25Oct16 07:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Directorate Change
28Sep16 07:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Advisor Changes
21Sep16 07:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Placing and Update on Acquisition
07Sep16 12:19
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Result of GM
22Aug16 07:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Notice of General Meeting
16Aug16 13:05
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Advisor Changes
16May16 07:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Extensions for Virtual Tumour Project
18Apr16 09:02
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Physiomics Appoints New Chief Executive Officer
04Apr16 12:12
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
New Speciality Pharma Customer for new Indication
31Mar16 07:01
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Interim Results Statement
31Mar16 07:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Heads of Terms with BioMoti and Board Changes
22Dec15 12:08
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Issue of Options
22Dec15 07:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
New Speciality Pharma Customer for New Indication
18Dec15 10:57
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Placing
14Dec15 10:29
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Result of General Meeting
27Nov15 16:15
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Notice of General Meeting
10Nov15 07:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Final Results
06Nov15 07:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Strategic Update
12Oct15 07:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
4th Large Pharma Customer for Virtual Tumour
09Oct15 07:00
RNS
PYC:LON
Physiomics Plc
Other
£2.10m
Project extension with global pharma company
«
1
2
»
Date / Time
Source
Company
% Chg
04Aug20 07:00
RNS
Physiomics Plc
14.81%
Trading update
31Jul20 07:00
RNS
Physiomics Plc
14.81%
Physiomics awarded contract by Astellas Pharma Inc
22Jul20 11:45
RNS
Physiomics Plc
14.81%
Share Price Movement
06Jul20 10:00
RNS
Physiomics Plc
14.81%
Director dealing
30Jun20 14:30
RNS
Physiomics Plc
14.81%
Contract award and update
22Jun20 07:00
RNS-R
Physiomics Plc
14.81%
Conference presentation
10Jun20 13:00
RNS
Physiomics Plc
14.81%
Holding(s) in Company
27May20 07:00
RNS
Physiomics Plc
14.81%
Fundraise
15May20 13:00
RNS
Physiomics Plc
14.81%
Holding(s) in Company
28Apr20 14:50
RNS-R
Physiomics Plc
14.81%
Conference attendance and presentation
16Apr20 07:00
RNS
Physiomics Plc
14.81%
Confirmation of Twitter account
09Apr20 12:28
RNS
Physiomics Plc
14.81%
Holding(s) in Company
06Apr20 07:00
RNS-R
Physiomics Plc
14.81%
Awarded further Bicycle Therapeutics contract
19Mar20 07:00
RNS
Physiomics Plc
14.81%
COVID-19 update
10Mar20 07:00
RNS
Physiomics Plc
14.81%
NIHR i4i award
05Mar20 07:00
RNS
Physiomics Plc
14.81%
Physiomics awarded further contract by Merck
03Mar20 07:01
RNS
Physiomics Plc
14.81%
Interim Results
03Mar20 07:00
RNS-R
Physiomics Plc
14.81%
Awarded two further contracts by Bicycle
27Dec19 15:45
RNS
Physiomics Plc
14.81%
Holding(s) in Company
23Dec19 07:00
RNS-R
Physiomics Plc
14.81%
Contract award
20Dec19 10:30
RNS
Physiomics Plc
14.81%
Merck Contracts
19Nov19 12:52
RNS
Physiomics Plc
14.81%
Result of AGM
21Oct19 07:00
RNS
Physiomics Plc
14.81%
Dispatch of Annual Report and Notice of AGM
30Sep19 07:00
RNS
Physiomics Plc
14.81%
Final Results for the Year Ended 30 June 2019
05Aug19 07:00
RNS
Physiomics Plc
14.81%
Director Dealing
30Jul19 07:00
RNS
Physiomics Plc
14.81%
Trading Update
22Jul19 09:03
RNS
Physiomics Plc
14.81%
Holding(s) in Company
08Jul19 07:00
RNS-R
Physiomics Plc
14.81%
Agreement with Bicycle and Cancer Research UK
02Jul19 13:30
RNS
Physiomics Plc
14.81%
Holding(s) in Company
28Jun19 07:00
RNS-R
Physiomics Plc
14.81%
Contract Award
31May19 07:00
RNS
Physiomics Plc
14.81%
Change of Adviser
14May19 07:00
RNS
Physiomics Plc
14.81%
Innovate UK Award Project
03May19 12:00
RNS-R
Physiomics Plc
14.81%
Physiomics participates at NIHR event
30Apr19 14:00
RNS-R
Physiomics Plc
14.81%
Conference attendance and presentation
27Mar19 13:00
RNS
Physiomics Plc
14.81%
Issue of Options
26Mar19 13:00
RNS
Physiomics Plc
14.81%
AIM Rule 26 Website Change
20Mar19 07:00
RNS-R
Physiomics Plc
14.81%
Conference Attendance and Presentation
21Feb19 07:00
RNS
Physiomics Plc
14.81%
Interim Results
07Jan19 07:00
RNS-R
Physiomics Plc
14.81%
Conference Attendance
03Jan19 07:00
RNS-R
Physiomics Plc
14.81%
Strategic Collaboration
17Dec18 07:00
RNS
Physiomics Plc
14.81%
Renewal of Agreement with Merck
20Nov18 12:56
RNS
Physiomics Plc
14.81%
Result of AGM
15Oct18 13:00
RNS
Physiomics Plc
14.81%
Dispatch of Annual Report and Shareholder Circular
08Oct18 07:00
RNS
Physiomics Plc
14.81%
Final Results for the Year Ended 30 June 2018
09Aug18 07:00
RNS
Physiomics Plc
14.81%
Contract award
21Jun18 07:00
RNS
Physiomics Plc
14.81%
Trading Update
23May18 07:00
RNS
Physiomics Plc
14.81%
Placing
26Apr18 11:06
RNS
Physiomics Plc
14.81%
Contract Award
06Apr18 14:40
RNS
Physiomics Plc
14.81%
Director/PDMR Shareholding
27Mar18 17:23
RNS
Physiomics Plc
14.81%
Issue of Options
14Mar18 07:00
RNS
Physiomics Plc
14.81%
Award of New Innovate UK Grant
19Feb18 07:00
RNS
Physiomics Plc
14.81%
Interim Results Statement
09Feb18 07:00
RNS
Physiomics Plc
14.81%
Contract Award
26Jan18 07:00
RNS
Physiomics Plc
14.81%
New Major Pharmaceutical Client
25Jan18 13:34
RNS
Physiomics Plc
14.81%
Holding(s) in Company
24Jan18 08:46
RNS
Physiomics Plc
14.81%
Holding(s) in Company
19Jan18 10:20
RNS
Physiomics Plc
14.81%
Holding(s) in Company
17Jan18 15:52
RNS
Physiomics Plc
14.81%
Holding(s) in Company
13Dec17 14:06
RNS
Physiomics Plc
14.81%
Result of AGM
12Dec17 10:17
RNS
Physiomics Plc
14.81%
Director Dealing
06Dec17 15:00
RNS
Physiomics Plc
14.81%
Issue of Equity
30Nov17 13:38
RNS
Physiomics Plc
14.81%
Share Price Movement
28Nov17 07:00
RNS
Physiomics Plc
14.81%
Clinical Project Completion and Services Agreement
09Nov17 07:00
RNS
Physiomics Plc
14.81%
Dispatch of Annual Report and Shareholder Circular
16Oct17 07:00
RNS
Physiomics Plc
14.81%
Final Results
02Oct17 07:00
RNS
Physiomics Plc
14.81%
Company Update
31Jul17 07:00
RNS
Physiomics Plc
14.81%
Two New Pre-Clinical Contracts
05May17 07:00
RNS
Physiomics Plc
14.81%
Physiomics to Present at BioTrinity 2017
24Mar17 11:15
RNS
Physiomics Plc
14.81%
Interim Results Statement
11Jan17 07:00
RNS
Physiomics Plc
14.81%
Company Update
06Jan17 07:00
RNS
Physiomics Plc
14.81%
Confirmation of Award of Innovate UK Grant
22Dec16 15:31
RNS
Physiomics Plc
14.81%
Director Dealing
22Dec16 07:00
RNS
Physiomics Plc
14.81%
Issue of Options
16Dec16 13:00
RNS
Physiomics Plc
14.81%
Result of AGM
05Dec16 07:00
RNS
Physiomics Plc
14.81%
Payment for in-silico modelling of inhibitor
23Nov16 07:00
RNS
Physiomics Plc
14.81%
Posting of Financial Results and Notice of AGM
22Nov16 07:00
RNS
Physiomics Plc
14.81%
Provisional Award of Innovate UK Grant
27Oct16 15:00
RNS
Physiomics Plc
14.81%
Final Results for the year ended 30 June 2016
25Oct16 07:00
RNS
Physiomics Plc
14.81%
Directorate Change
28Sep16 07:00
RNS
Physiomics Plc
14.81%
Advisor Changes
21Sep16 07:00
RNS
Physiomics Plc
14.81%
Placing and Update on Acquisition
07Sep16 12:19
RNS
Physiomics Plc
14.81%
Result of GM
22Aug16 07:00
RNS
Physiomics Plc
14.81%
Notice of General Meeting
16Aug16 13:05
RNS
Physiomics Plc
14.81%
Advisor Changes
16May16 07:00
RNS
Physiomics Plc
14.81%
Extensions for Virtual Tumour Project
18Apr16 09:02
RNS
Physiomics Plc
14.81%
Physiomics Appoints New Chief Executive Officer
04Apr16 12:12
RNS
Physiomics Plc
14.81%
New Speciality Pharma Customer for new Indication
31Mar16 07:01
RNS
Physiomics Plc
14.81%
Interim Results Statement
31Mar16 07:00
RNS
Physiomics Plc
14.81%
Heads of Terms with BioMoti and Board Changes
22Dec15 12:08
RNS
Physiomics Plc
14.81%
Issue of Options
22Dec15 07:00
RNS
Physiomics Plc
14.81%
New Speciality Pharma Customer for New Indication
18Dec15 10:57
RNS
Physiomics Plc
14.81%
Placing
14Dec15 10:29
RNS
Physiomics Plc
14.81%
Result of General Meeting
27Nov15 16:15
RNS
Physiomics Plc
14.81%
Notice of General Meeting
10Nov15 07:00
RNS
Physiomics Plc
14.81%
Final Results
06Nov15 07:00
RNS
Physiomics Plc
14.81%
Strategic Update
12Oct15 07:00
RNS
Physiomics Plc
14.81%
4th Large Pharma Customer for Virtual Tumour
09Oct15 07:00
RNS
Physiomics Plc
14.81%
Project extension with global pharma company
«
1
2
»
Date / Time
Company
% Chg
04Aug20 07:00
Physiomics Plc
14.81%
Trading update
31Jul20 07:00
Physiomics Plc
14.81%
Physiomics awarded contract by Astellas Pharma Inc
22Jul20 11:45
Physiomics Plc
14.81%
Share Price Movement
06Jul20 10:00
Physiomics Plc
14.81%
Director dealing
30Jun20 14:30
Physiomics Plc
14.81%
Contract award and update
22Jun20 07:00
Physiomics Plc
14.81%
Conference presentation
10Jun20 13:00
Physiomics Plc
14.81%
Holding(s) in Company
27May20 07:00
Physiomics Plc
14.81%
Fundraise
15May20 13:00
Physiomics Plc
14.81%
Holding(s) in Company
28Apr20 14:50
Physiomics Plc
14.81%
Conference attendance and presentation
16Apr20 07:00
Physiomics Plc
14.81%
Confirmation of Twitter account
09Apr20 12:28
Physiomics Plc
14.81%
Holding(s) in Company
06Apr20 07:00
Physiomics Plc
14.81%
Awarded further Bicycle Therapeutics contract
19Mar20 07:00
Physiomics Plc
14.81%
COVID-19 update
10Mar20 07:00
Physiomics Plc
14.81%
NIHR i4i award
05Mar20 07:00
Physiomics Plc
14.81%
Physiomics awarded further contract by Merck
03Mar20 07:01
Physiomics Plc
14.81%
Interim Results
03Mar20 07:00
Physiomics Plc
14.81%
Awarded two further contracts by Bicycle
27Dec19 15:45
Physiomics Plc
14.81%
Holding(s) in Company
23Dec19 07:00
Physiomics Plc
14.81%
Contract award
20Dec19 10:30
Physiomics Plc
14.81%
Merck Contracts
19Nov19 12:52
Physiomics Plc
14.81%
Result of AGM
21Oct19 07:00
Physiomics Plc
14.81%
Dispatch of Annual Report and Notice of AGM
30Sep19 07:00
Physiomics Plc
14.81%
Final Results for the Year Ended 30 June 2019
05Aug19 07:00
Physiomics Plc
14.81%
Director Dealing
30Jul19 07:00
Physiomics Plc
14.81%
Trading Update
22Jul19 09:03
Physiomics Plc
14.81%
Holding(s) in Company
08Jul19 07:00
Physiomics Plc
14.81%
Agreement with Bicycle and Cancer Research UK
02Jul19 13:30
Physiomics Plc
14.81%
Holding(s) in Company
28Jun19 07:00
Physiomics Plc
14.81%
Contract Award
31May19 07:00
Physiomics Plc
14.81%
Change of Adviser
14May19 07:00
Physiomics Plc
14.81%
Innovate UK Award Project
03May19 12:00
Physiomics Plc
14.81%
Physiomics participates at NIHR event
30Apr19 14:00
Physiomics Plc
14.81%
Conference attendance and presentation
27Mar19 13:00
Physiomics Plc
14.81%
Issue of Options
26Mar19 13:00
Physiomics Plc
14.81%
AIM Rule 26 Website Change
20Mar19 07:00
Physiomics Plc
14.81%
Conference Attendance and Presentation
21Feb19 07:00
Physiomics Plc
14.81%
Interim Results
07Jan19 07:00
Physiomics Plc
14.81%
Conference Attendance
03Jan19 07:00
Physiomics Plc
14.81%
Strategic Collaboration
17Dec18 07:00
Physiomics Plc
14.81%
Renewal of Agreement with Merck
20Nov18 12:56
Physiomics Plc
14.81%
Result of AGM
15Oct18 13:00
Physiomics Plc
14.81%
Dispatch of Annual Report and Shareholder Circular
08Oct18 07:00
Physiomics Plc
14.81%
Final Results for the Year Ended 30 June 2018
09Aug18 07:00
Physiomics Plc
14.81%
Contract award
21Jun18 07:00
Physiomics Plc
14.81%
Trading Update
23May18 07:00
Physiomics Plc
14.81%
Placing
26Apr18 11:06
Physiomics Plc
14.81%
Contract Award
06Apr18 14:40
Physiomics Plc
14.81%
Director/PDMR Shareholding
27Mar18 17:23
Physiomics Plc
14.81%
Issue of Options
14Mar18 07:00
Physiomics Plc
14.81%
Award of New Innovate UK Grant
19Feb18 07:00
Physiomics Plc
14.81%
Interim Results Statement
09Feb18 07:00
Physiomics Plc
14.81%
Contract Award
26Jan18 07:00
Physiomics Plc
14.81%
New Major Pharmaceutical Client
25Jan18 13:34
Physiomics Plc
14.81%
Holding(s) in Company
24Jan18 08:46
Physiomics Plc
14.81%
Holding(s) in Company
19Jan18 10:20
Physiomics Plc
14.81%
Holding(s) in Company
17Jan18 15:52
Physiomics Plc
14.81%
Holding(s) in Company
13Dec17 14:06
Physiomics Plc
14.81%
Result of AGM
12Dec17 10:17
Physiomics Plc
14.81%
Director Dealing
06Dec17 15:00
Physiomics Plc
14.81%
Issue of Equity
30Nov17 13:38
Physiomics Plc
14.81%
Share Price Movement
28Nov17 07:00
Physiomics Plc
14.81%
Clinical Project Completion and Services Agreement
09Nov17 07:00
Physiomics Plc
14.81%
Dispatch of Annual Report and Shareholder Circular
16Oct17 07:00
Physiomics Plc
14.81%
Final Results
02Oct17 07:00
Physiomics Plc
14.81%
Company Update
31Jul17 07:00
Physiomics Plc
14.81%
Two New Pre-Clinical Contracts
05May17 07:00
Physiomics Plc
14.81%
Physiomics to Present at BioTrinity 2017
24Mar17 11:15
Physiomics Plc
14.81%
Interim Results Statement
11Jan17 07:00
Physiomics Plc
14.81%
Company Update
06Jan17 07:00
Physiomics Plc
14.81%
Confirmation of Award of Innovate UK Grant
22Dec16 15:31
Physiomics Plc
14.81%
Director Dealing
22Dec16 07:00
Physiomics Plc
14.81%
Issue of Options
16Dec16 13:00
Physiomics Plc
14.81%
Result of AGM
05Dec16 07:00
Physiomics Plc
14.81%
Payment for in-silico modelling of inhibitor
23Nov16 07:00
Physiomics Plc
14.81%
Posting of Financial Results and Notice of AGM
22Nov16 07:00
Physiomics Plc
14.81%
Provisional Award of Innovate UK Grant
27Oct16 15:00
Physiomics Plc
14.81%
Final Results for the year ended 30 June 2016
25Oct16 07:00
Physiomics Plc
14.81%
Directorate Change
28Sep16 07:00
Physiomics Plc
14.81%
Advisor Changes
21Sep16 07:00
Physiomics Plc
14.81%
Placing and Update on Acquisition
07Sep16 12:19
Physiomics Plc
14.81%
Result of GM
22Aug16 07:00
Physiomics Plc
14.81%
Notice of General Meeting
16Aug16 13:05
Physiomics Plc
14.81%
Advisor Changes
16May16 07:00
Physiomics Plc
14.81%
Extensions for Virtual Tumour Project
18Apr16 09:02
Physiomics Plc
14.81%
Physiomics Appoints New Chief Executive Officer
04Apr16 12:12
Physiomics Plc
14.81%
New Speciality Pharma Customer for new Indication
31Mar16 07:01
Physiomics Plc
14.81%
Interim Results Statement
31Mar16 07:00
Physiomics Plc
14.81%
Heads of Terms with BioMoti and Board Changes
22Dec15 12:08
Physiomics Plc
14.81%
Issue of Options
22Dec15 07:00
Physiomics Plc
14.81%
New Speciality Pharma Customer for New Indication
18Dec15 10:57
Physiomics Plc
14.81%
Placing
14Dec15 10:29
Physiomics Plc
14.81%
Result of General Meeting
27Nov15 16:15
Physiomics Plc
14.81%
Notice of General Meeting
10Nov15 07:00
Physiomics Plc
14.81%
Final Results
06Nov15 07:00
Physiomics Plc
14.81%
Strategic Update
12Oct15 07:00
Physiomics Plc
14.81%
4th Large Pharma Customer for Virtual Tumour
09Oct15 07:00
Physiomics Plc
14.81%
Project extension with global pharma company
«
1
2
»
Strapline
Strapline
Question 1
Answer 1
Question 2
Answer 2
Question 3
Answer 3
Question 4
Answer 4
Question 5
Answer 5
Question 6
Answer 6
Question 7
Answer 7
Question 8
Answer 8
Top
Home
Features
Pricing
Event Hub
Reg.News
Short Interest Tracker
Explore Content
Regions
UK
Rest of EMEA
N America
APAC
LatAm
Exchanges
Aquis Apex
Australian Securities Exchange
Canadian Securities Exchange
Euronext Paris
London Stock Exchange (domestic)
SIX Swiss Exchange
Sectors
Automobile Industry
Banks
Building & Construction
Chemicals
Discretionary Personal Goods
Discretionary Retail
Energy
ETFs
Financial Services
Food & Drink
Food Production
Health
Household Goods & DIY
Industrial Equipment, Goods & Services
Insurance & Reinsurance
Investment Trusts
Leisure, Tourism & Travel
Media
Open-ended Funds
Other
Real Estate
Resources
Staple Retail
Technology
Telecoms
Utilities
Small / Large Cap
UK100
UK250
UK Smallcap
UK Other Main Markets
Other
Private/EIS
EIS Single Company
EIS/SEIS Funds
IHT Products
SEIS Single Company
VCT Funds
Providers
Free/Commissioned
ACF Equity Research
Actio Advisors
Align Research
Atrium Research
BlytheRay
BNP Paribas Exane - Sponsored Research
Brand Communications
BRR Media
Calvine Partners
Capital Access Group
Capital Markets Brokers
Cavendish
Checkpoint Partners
Clear Capital Markets
Couloir Capital
Degroof Petercam
DirectorsTalk
Doceo
Edison
Equity Development
eResearch
Fidante Partners
Five Minute Pitch TV
focusIR
Fundamental Research Corp
Galliano’s Latin Notes
goetzpartners securities Limited
H2 Radnor
Hardman & Co
Holland Advisors
Hypothesis Research
Inbound Capital
Independent Investment Research
InterAxS Global
Kepler | Trust Intelligence
Liberum
London Stock Exchange
Magnitogorsk Iron and steel works
Mello Events
Mining Network
NuWays
Paul Scott
Peel Hunt
piworld.co.uk
Proactive
Progressive Equity Research
Quantum Research Group
QuotedData
RaaS - Research as a Service
Research Tree
Resolve Research
SEAL Advisors Ltd
ShareSoc
Shore Capital
Small Cap Consumer Research LLC
StockBox
Tennyson Securities
The AIC
The Life Sciences Division
Trinity Delta
Turner Pope Investments
UK Investor Group
Vox Markets
VSA Capital
WHIreland
Winterflood Securities
Yellowstone Advisory
Zeus Capital
High Net Worth Offering
Fox-Davies Capital
ACF Equity Research
Align Research
Allenby Capital
AlphaValue
Alternative Resource Capital
Arctic Securities
Arden Partners
Auctus Advisors
Baptista Research
BNP Paribas Exane - Sponsored Research
Canaccord Genuity
Cavendish
Couloir Capital
Dowgate Capital
First Berlin
First Sentinel
GSBR Research
Hannam & Partners
Hybridan
Kemeny Capital
Liberum
Longspur Clean Energy
Louis Capital
Magnitogorsk Iron and steel works
Medley Global Advisors
Northland Capital Partners
QuotedData Professional
Shard Capital
ShareSoc
Shore Capital
Singer Capital Markets
SP Angel
Stanford Capital Partners
Stifel FirstEnergy
Stockdale Securities
Tamesis Partners
Tennyson Securities
The Life Sciences Division
Turner Pope Investments
VSA Capital
WHIreland
Whitman Howard
Yellowstone Advisory
Zeus Capital
Institutional Offering
Fox-Davies Capital
ACF Equity Research
Align Research
Allenby Capital
Alternative Resource Capital
Arctic Securities
Arden Partners
Auctus Advisors
BNP Paribas Exane
BRR Media
Calvine Partners
Canaccord Genuity
Capital Access Group
Cavendish
Checkpoint Partners
Clear Capital Markets
Couloir Capital
Degroof Petercam
DirectorsTalk
Doceo
Dowgate Capital
Edison
Equity Development
eResearch
Fidante Partners
First Berlin
First Sentinel
Five Minute Pitch TV
Fundamental Research Corp
Galliano’s Latin Notes
Goodbody
H2 Radnor
Hannam & Partners
Hardman & Co
Holland Advisors
Hybridan
Inbound Capital
Independent Investment Research
InterAxS Global
Investec Bank
Kemeny Capital
Kepler | Absolute Hedge
Kepler | Trust Intelligence
Liberum
London Stock Exchange
Longspur Clean Energy
Magnitogorsk Iron and steel works
Mello Events
Mining Network
Northland Capital Partners
Numis
NuWays
Panmure Gordon
Peel Hunt
piworld.co.uk
Proactive
Quantum Research Group
QuotedData
RaaS - Research as a Service
Research Tree
Shard Capital
ShareSoc
Shore Capital
Singer Capital Markets
Small Cap Consumer Research LLC
SP Angel
Stanford Capital Partners
Stifel
StockBox
Tamesis Partners
Tennyson Securities
The AIC
The Life Sciences Division
Trinity Delta
UK Investor Group
Velocity Trade
Vox Markets
VSA Capital
WHIreland
Winterflood Securities
Yellowstone Advisory
Zeus Capital
Contact
Sign Up
Sign In
Share: